Frédéric Thuaud

eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies

Lise Boussemart, Hélène Malka-Mahieu, Isabelle Girault et al. · Nature · 2014 · 360 citations

Medicine, Cancer Biology, Oncology +11

The Natural Anticancer Compounds Rocaglamides Inhibit the Raf-MEK-ERK Pathway by Targeting Prohibitin 1 and 2

Gernot Polier, Jennifer Neumann, Frédéric Thuaud et al. · Chemistry & Biology · 2012 · 161 citations

Medicine, Oncology, Pharmacology +13

Synthetic Analogue of Rocaglaol Displays a Potent and Selective Cytotoxicity in Cancer Cells: Involvement of Apoptosis Inducing Factor and Caspase-12

Frédéric Thuaud, Yohann Bernard, Gülen Türkeri et al. · Journal of Medicinal Chemistry · 2009 · 114 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Flavaglines as Potent Anticancer and Cytoprotective Agents

Nigel Ribeiro, Frédéric Thuaud, Yohann Bernard et al. · Journal of Medicinal Chemistry · 2012 · 74 citations

Medicine, Oncology, Pharmacology +16

Assessment of flavaglines as potential chikungunya virus entry inhibitors

Phitchayapak Wintachai, Frédéric Thuaud, Christine Basmadjian et al. · Microbiology and Immunology · 2015 · 65 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +16